US Patent Issued to The Regents of the University of California on May 26 for "Tetracyclic compounds for treating brain disorders" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,464, issued on May 26, was assigned to The Regents of the University of California (Oakland, Calif.).

"Tetracyclic compounds for treating brain disorders" was invented by David E. Olson (Oakland, Calif.), Jeremy R. Tuck (Oakland, Calif.) and Lee E. Dunlap (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are tetracyclic heterocyclic compounds which can be useful for methods of treating a disease or for increasing neural plasticity. The compounds can also be useful for increasing dendritic spine density."

The patent was filed on April 13, 2022, under Application No. 18/554,762.

*For further information, including images...